125
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Influences of Two FEV1 Reference Equations (GLI-2012 and GIRH-2017) on Airflow Limitation Classification Among COPD Patients

, , , , , , , & show all
Pages 2053-2065 | Received 09 May 2022, Accepted 17 Aug 2022, Published online: 02 Sep 2022

References

  • Singh D, Agusti A, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019. Eur Respir J. 2019;53(5):1900164. doi:10.1183/13993003.00164-2019
  • Lung Function Professional Group of Chinese Respiratory Society. Guidelines for lung function examination (part 2) – spirometer examination. Chin J Tubercul Respir. 2014;2014:481–486.
  • Talaminos BA, Márquez ME, Roa RL, et al. Factors affecting lung function: a review of the literature. Arch Bronconeumol. 2018;54(6):327–332. doi:10.1016/j.arbres.2018.01.030
  • Zheng J, Zhong N. Normative values of pulmonary function testing in Chinese adults. Chin Med J. 2002;115(1):50–54.
  • Quanjer PH, Stanojevic S, Cole TJ, et al. Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations. Eur Respir J. 2012;40(6):1324–1343. doi:10.1183/09031936.00080312
  • Jian W, Gao Y, Hao C, et al. Reference values for spirometry in Chinese aged 4–80 years. J Thorac Dis. 2017;9(11):4538–4549. doi:10.21037/jtd.2017.10.110
  • Ben SH, El AM, Hadj MK, et al. The recent multi-ethnic global lung initiative 2012 (GLI2012) reference values don’t reflect contemporary adult’s North African spirometry. Respir Med. 2013;107(12):2000–2008. doi:10.1016/j.rmed.2013.10.015
  • Leuschner G, Lauseker M, Howanietz AS, et al. Longitudinal lung function measurements in single lung transplant recipients with chronic lung allograft dysfunction. J Heart Lung Transplant. 2020;39(11):1270–1278. doi:10.1016/j.healun.2020.08.008
  • Sugawara K, Mori K, Okumura Y, et al. Preoperative low vital capacity influences survival after esophagectomy for patients with esophageal carcinoma. World J Surg. 2020;44(7):2305–2313. doi:10.1007/s00268-020-05450-0
  • Zhong N, Wang C, Yao W, et al. Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey. Am J Respir Crit Care Med. 2007;176(8):753–760. doi:10.1164/rccm.200612-1749OC
  • Lange P, Celli B, Agusti A, et al. Lung-function trajectories leading to chronic obstructive pulmonary disease. N Engl J Med. 2015;373(2):111–122. doi:10.1056/NEJMoa1411532
  • Soumagne T, Laveneziana P, Veil-Picard M, et al. Asymptomatic subjects with airway obstruction have significant impairment at exercise. Thorax. 2016;71(9):804–811. doi:10.1136/thoraxjnl-2015-207953
  • Cui J, Zhou Y, Tian J, et al. A discriminant function model as an alternative method to spirometry for COPD screening in primary care settings in China. J Thorac Dis. 2012;4(6):594–600. doi:10.3978/j.issn.2072-1439.2012.11.06
  • Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease (2021 reports). 2021.
  • Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319–338. doi:10.1183/09031936.05.00034805
  • Zhou YM, Chen SY, Tian J, et al. Development and validation of a chronic obstructive pulmonary disease screening questionnaire in China. Int J Tuberc Lung Dis. 2013;17(12):1645–1651. doi:10.5588/ijtld.12.0995
  • Tian J, Zhou Y, Cui J, et al. Peak expiratory flow as a screening tool to detect airflow obstruction in a primary health care setting. Int J Tuberc Lung Dis. 2012;16(5):674–680. doi:10.5588/ijtld.11.0429
  • Liu S, Zhou Y, Liu S, et al. Association between exposure to ambient particulate matter and chronic obstructive pulmonary disease: results from a cross-sectional study in China. Thorax. 2017;72(9):788–795. doi:10.1136/thoraxjnl-2016-208910
  • Jones PW, Harding G, Berry P, et al. Development and first validation of the COPD Assessment Test. Eur Respir J. 2009;34(3):648–654. doi:10.1183/09031936.00102509
  • Zhou Z, Zhou A, Zhao Y, et al. Evaluating the clinical COPD questionnaire: a systematic review. Respirology. 2017;22(2):251–262. doi:10.1111/resp.12970
  • Bestall JC, Paul EA, Garrod R, et al. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54(7):581–586. doi:10.1136/thx.54.7.581
  • Wang C, Xu J, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study. Lancet. 2018;391(10131):1706–1717. doi:10.1016/S0140-6736(18)30841-9
  • Miller MR, Pedersen OF. New concepts for expressing forced expiratory volume in 1 s arising from survival analysis. Eur Respir J. 2010;35(4):873–882. doi:10.1183/09031936.00025809
  • Miller MR, Pedersen OF, Dirksen A. A new staging strategy for chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2007;2(4):657–663.
  • Quanjer PH, Pretto JJ, Brazzale DJ, et al. Grading the severity of airways obstruction: new wine in new bottles. Eur Respir J. 2014;43(2):505–512. doi:10.1183/09031936.00086313
  • Quanjer PH, Tammeling GJ, Cotes JE, et al. Lung volumes and forced ventilatory flows. Eur Respir J. 1993;6(Suppl 16):5–40. doi:10.1183/09041950.005s1693
  • Duong M, Islam S, Rangarajan S, et al. Global differences in lung function by region (PURE): an international, community-based prospective study. Lancet Respir Med. 2013;1(8):599–609. doi:10.1016/S2213-2600(13)70164-4
  • Vaz FC, Concato J, Mcavay G, et al. The ratio of FEV1 to FVC as a basis for establishing chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2010;181(5):446–451. doi:10.1164/rccm.200909-1366OC
  • Schroeder SA. New evidence that cigarette smoking remains the most important health hazard. N Engl J Med. 2013;368(4):389–390. doi:10.1056/NEJMe1213751
  • Landis SH, Muellerova H, Mannino DM, et al. Continuing to Confront COPD International Patient Survey: methods, COPD prevalence, and disease burden in 2012–2013. Int J Chron Obstruct Pulmon Dis. 2014;9:597–611. doi:10.2147/COPD.S61854
  • Foreman MG, Zhang L, Murphy J, et al. Early-onset chronic obstructive pulmonary disease is associated with female sex, maternal factors, and African American race in the COPDGene Study. Am J Respir Crit Care Med. 2011;184(4):414–420. doi:10.1164/rccm.201011-1928OC
  • Silverman EK, Weiss ST, Drazen JM, et al. Gender-related differences in severe, early-onset chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000;162(6):2152–2158. doi:10.1164/ajrccm.162.6.2003112
  • Tam A, Churg A, Wright JL, et al. Sex differences in airway remodeling in a mouse model of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2016;193(8):825–834. doi:10.1164/rccm.201503-0487OC
  • Pavord ID, Yousaf N, Birring SS. Chronic obstructive pulmonary disease in non-smokers. Lancet. 2009;374(9706):1964, 1965–1966. doi:10.1016/S0140-6736(09)62114-0
  • Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary. Am J Respir Crit Care Med. 2017;195(5):557–582. doi:10.1164/rccm.201701-0218PP
  • Anane I, Guezguez F, Knaz H, et al. How to stage airflow limitation in stable chronic obstructive pulmonary disease male patients? Am J Men's Health. 2020;14(3):1819200518. doi:10.1177/1557988320922630
  • Hegendörfer E, Vaes B, Andreeva E, et al. Predictive value of different expressions of forced expiratory volume in 1 second (FEV1) for adverse outcomes in a cohort of adults aged 80 and older. J Am Med Dir Assoc. 2017;18(2):123–130. doi:10.1016/j.jamda.2016.08.012
  • Huang TH, Hsiue TR, Lin SH, et al. Comparison of different staging methods for COPD in predicting outcomes. Eur Respir J. 2018;51(3):1700577. doi:10.1183/13993003.00577-2017
  • Pedone C, Scarlata S, Scichilone N, et al. Alternative ways of expressing FEV 1 and mortality in elderly people with and without COPD. Eur Respir J. 2013;41(4):800–805. doi:10.1183/09031936.00008812
  • Waschki B, Kirsten AM, Holz O, et al. Disease progression and changes in physical activity in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2015;192(3):295–306. doi:10.1164/rccm.201501-0081OC
  • Waschki B, Kirsten A, Holz O, et al. Physical activity is the strongest predictor of all-cause mortality in patients with COPD: a prospective cohort study. Chest. 2011;140(2):331–342. doi:10.1378/chest.10-2521
  • Gimeno-Santos E, Frei A, Steurer-Stey C, et al. Determinants and outcomes of physical activity in patients with COPD: a systematic review. Thorax. 2014;69(8):731–739. doi:10.1136/thoraxjnl-2013-204763